ONLINE:

Clinical Operations Strategy Meeting

Following fantastic feedback we’re thrilled to announce we will be running another Online Clinical Operations Strategy Meeting. This virtual conference format allows you to discuss key clinical operations issues with your peers and forge new connections from the comfort of your own home.

Dates

16 Nov, 2020

Location

Online Location details

ONLINE STRATEGY MEETING EXPERIENCE

Clinical operations insights without leaving your home

Need a unique online conference experience? Looking for a chance for real discussions and genuine networking? Proventa International’s online clinical operations strategy meetings help you make those important connections through interactive roundtable discussions and keynote panel debates – all in a totally online format.

Join life science professionals from all over the world in debating the hottest topics in clinical trials. Engage with your senior peers, discover new insights and help take your company to the next level.

Download the Full Strategy Meeting Brochure

Strategy Meetings

What makes our online strategy meetings unique?

With senior delegation from big pharma and innovative biotech from all over the globe, you can network with peers from different locations, all in one place.

Roundtable Discussions

Intimate discussions leads by a renowned clinical and PV experts. Have your voice heard and debate alongside like-minded life science executives.

Global Networking

With senior delegation from big pharma and innovative biotech from all over the globe, you can network with peers from different locations, all in one place.

Personalised Agenda

Choose the topics that matter to you. From patient recruitment to risk-based monitoring to AI and machine learning; you design your agenda.rn

Totally online format

It’s more important than ever to encourage collaboration while promoting safety and accessibility. And that’s exactly what you can expect from our online meeting format.

Meet the Facilitators

Our panel of facilitators play a key role in shaping the agenda. See who will be bringing their expertise to the table.

Guillermo Caletti

Head of Clinical Operation Boehringer Ingelheim

Justin Stark

Head of Innovation, Trial Monitoring Novartis

Jessica Lee

SVP Clinical Operations & Global Integration Inovio Pharmaceuticals

Pernilla Sandwall

Chief Operating Officer InDex Pharmaceuticals

William Blumentals

Head of Pharmacoepidemiology Sanofi Genzyme

Frank Leu

CEO Novapeutics

Teresa Lamantia

VP, Global Quality and Transformation IQVIA

Jonathan Rabinowitz

Professor Bar-Ilan University

Jonathan Rabinowitz is an Elie Wiesel Professor at Bar Ilan University and a visiting professor at Mount Sinai School of Medicine in New York. He is the Founder and Director of DupCheck, and his research focuses on improving safety and efficiency of clinical trials. Jonathan is the academic lead of the Advanced Data Analysis Techniques group at European Union Innovative Medicines Initiative funded NEMWEDS, one of the largest ever collaboration projects directed at finding safer and more efficient drug development methods. Jonathan did his Doctoral training in Statistics at Bar Ilan University and in Social Welfare at Yeshiva University, and serves on advisory groups at FDA and EMA. He is a member of the American College of Neuropsychopharmacology, and is on the Executive Committee of International Society for CNS Clinical Trials and Methodology, and serves as co-chair of the working group on consistency in measurement. He has over 170 scientific publications.

Vladimir Bulatov

CSO Novartis Russia

Prasun Mishra

Founder & Chief Executive Officer Agility Pharmaceuticals

Stephanie Langouet

COO Cmed

Magali Taiel

CMO Gensight Biologics

Dr. Taiel completed her doctorate in Medicine with board certification in Ophthalmology from Lariboisiere Saint Louis University, Paris, France, in 1993, and her Associate Professor degree in 1998. Dr Taiel completed her internship at academic Paris hospitals, was an Associate Professor of Ophthalmology, served as an Ophthalmology Department Head, and ran Surgical and Medical Ophthalmology private practice. After 13 years of Ophthalmology public and private practice, Dr Taiel has been engaged in the Pharma Industry for 20 years; she brings extensive experience and expertise in drug clinical development, gene therapy, and medical affairs. She started her career at Servier company headquarter, and then worked in Ophthalmology area at Pfizer for several years; she then held international and management positions in various therapeutic areas, including both technical and supervision duties, at Eli Lilly Company for many years. Then, as VP Clinical Development, she led Clinical Development and Operations, to develop antisense oligonucleotides in Inherited Retinal diseases at ProQR Therapeutics. She then moved to GenSight-Biologics in 2018, to supervise the Medical Department and lead Gene Therapy programs in Inherited Retinal and Neuro-Ophthalmology diseases, as the CMO of the company. Dr. Taiel has authored numerous protocols and articles published in peer reviewed journals, and made critical contributions to successful clinical development and launch of many products. She brings extensive years of experience from both academic medicine and the pharma industry.

Eyal Ron

Chief Technical Officer Polyrizon Biotech

David Hadden

Co-Founder and Chief-Game-Changer Pro-ficiency

Zabir Macci

Centralized Monitoring Manager, Clinical Operations Process Design & Analytics IQVIA IQVIA

Ann Baker

Vice President, R&D Consulting Services IQVIA

Dr. Claudia Hesselmann, PhD

Co-Founder & CEO, Germany Arensia

Reasons To Attend the Virtual Conference

Fully Interactive Virtual Conference

We’re all bored of the same webinar format by now. Instead, join intimate groups of like-minded professionals and discuss the topics that really matter to you

Personalised and Easy to Join Agenda

Pick the roundtable discussions that you want to be part of. Simply choose your sessions and we will send you the direct links and calendar reminder to join

Senior Decision Makers

All our roundtable discussions are aimed at director level and above. Discover how your peers are tackling the industries biggest challenges and have your thoughts heard

Private and Intimate Discussions

Each sessions is ;ead by an industry expert and the roundtbales are limited to ensure you have fruitful and genuine conversations with your colleagues

Agenda

Find Your Roundtable Topics

RISK BASED MONITORING – How to develop a Monitoring Plan to incorporate a risk-based approach?

PATIENT RECRUITMENT / PATIENT CENTRICITY – How can we further improve patient centricity to improve patient retainment and recruitment?

EMERGING BIOPHARMA – Achieving proof-of-concept results quickly and with quality in mind

CLINICAL OUTSOURCING – Ensuring strong and efficient vendor oversight and communication

CLINICAL DATA/RWE – Will we ever adpot a unviversal clinical data standard?

A.I & DISRUPTIVE TECHNOLOGY – Utilising eCOA, ePRO & eSOURCE to Improve protocol compliance and minimise errors by patients on entry point

RISK BASED MONITORING – Will RBM ever become “business as usual”?

PATIENT RECRUITMENT / PATIENT CENTRICITY – Increasing patient reach while maintaining retention for trials which require frequent site visits

EMERGING BIOPHARMA – Transitioning from early phase to late phase development – invest in in-house capabilities or outsource?

CLINICAL OUTSOURCING – Does one size fit all when you are looking for the best CRO for your clinical operations?

CLINICAL DATA/RWE – Improving the aggregation, cleaning and transforming of clinical trial data from multiple sources

A.I & DISRUPTIVE TECHNOLOGY – Optimising clinical trials by implementing a shared investigator platform to streamline and integrate data as well as support communication between investigators and sponsors